B HALL STRATEGIES, LLC

Lobbying for TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC. · Pharmaceutical company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · Senate · $30,000.00 income · posted Jul 19, 2026

Bills named in this filing 1

Lobbying activity 1

Pharmacy

Issues related to drug pricing. H.R.4299/S.__ - Protecting Patient Access to Cancer and Complex Therapies Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.